Urinary Liver Type Fatty Acid Binding Protein Is Negatively Associated With Estimated Glomerular Filtration Rate in Renal Transplant Recipients With Graft Loss.

[1]  Yuanyuan Xie,et al.  L-FABP: A novel biomarker of kidney disease. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[2]  J. Ishii,et al.  Serum liver‐type fatty acid‐binding protein predicts recovery of graft function after kidney transplantation from donors after cardiac death , 2014, Clinical transplantation.

[3]  V. Dalbo,et al.  Clinical and research markers of oxidative stress in chronic kidney disease , 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[4]  T. Sugaya,et al.  Urinary Fatty Acids and Liver-Type Fatty Acid Binding Protein in Diabetic Nephropathy , 2009, Nephron Clinical Practice.

[5]  H. Taniguchi,et al.  Renal L-type fatty acid--binding protein in acute ischemic injury. , 2007, Journal of the American Society of Nephrology : JASN.

[6]  M. Yamanouchi,et al.  Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease , 2006, Molecular and Cellular Biochemistry.

[7]  F. Burczynski,et al.  Antioxidative function of L‐FABP in L‐FABP stably transfected Chang liver cells , 2005, Hepatology.

[8]  O. Erel.  A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. , 2003, Clinical biochemistry.

[9]  M. Yamanouchi,et al.  Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. , 2003, The Journal of laboratory and clinical medicine.

[10]  F. Cuccurullo,et al.  Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. , 2001, Free radical biology & medicine.